Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1-Reference-Cited by-同舟云学术

Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1

Published:2016-09 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Garcia Edwin, ,Hayden Annette,Birts Charles,Britton Edward,Cowie Andrew,Pickard Karen,Mellone Massimiliano,Choh Clarisa,Derouet Mathieu,Duriez Patrick,Noble Fergus,White Michael J.,Primrose John N.,Strefford Jonathan C.,Rose-Zerilli Matthew,Thomas Gareth J.,Ang Yeng,Sharrocks Andrew D.,Fitzgerald Rebecca C.,Underwood Timothy J.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep32417.pdf

Reference51 articles.

1. Noble, F. et al. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus. World J. Gastroenterol. 19, 9282–9293 (2013).

2. Vaughan, T. L. & Fitzgerald, R. C. Precision prevention of oesophageal adenocarcinoma. Nature reviews. Gastroenterology & hepatology 12, 243–248, doi: 10.1038/nrgastro.2015.24 (2015).

3. Dulak, A. M. et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat. Genet. 45, 478–486 (2013).

4. Weaver, J. M. et al. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nat. Genet. 46, 837–843 (2014).

5. Nones, K. et al. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nat Commun 5, 5224, doi: 10.1038/ncomms6224 (2014).

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modelling esophageal adenocarcinoma and Barrett’s esophagus with patient-derived organoids;Frontiers in Molecular Biosciences;2024-04-24

2. Systems toxicology to advance human and environmental hazard assessment: A roadmap for advanced materials;Nano Today;2023-02

3. Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches;Cancers;2022-07-30

4. Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts;Cell Reports Medicine;2022-06

5. Interception of Signaling Circuits of Esophageal Adenocarcinoma Cells by Resveratrol Reveals Molecular and Immunomodulatory Signatures;Cancers;2021-11-19